UniProtKB/Swiss-Prot Q13043: Variant p.Ile355Thr

Serine/threonine-protein kinase 4
Gene: STK4
Feedback?

Variant information Variant position:

355 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Isoleucine (I) to Threonine (T) at position 355 (I355T, p.Ile355Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (I) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs35944046 [ dbSNP | Ensembl ]

Sequence information Variant position:

355 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

487 The length of the canonical sequence.
Location on the sequence:

GDEMGTVRVASTMTDGANTM I EHDDTLPSQLGTMVINAEDE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GDEMGTVRVASTMTD-GANTMIEHDDTLPSQLGTMVINAEDE

Rhesus macaque                GDEMGTVRVASTMTD-GASTMIEHDDTLPSQLGTMVINTED

Mouse                         GDEMGTVRVASTMSG-GANTMIEHGDTLPSQLGTMVINTED

Bovine                        GDEMGTVRVASSMSD-GANTMIEHDDTLPSQLGTMVINTED

Chicken                       GDETGTIRVVNTMSD-GANTMIEHDGTLESQLGTMVINTED

Xenopus laevis                GKDLNTMKELGMMSE-GADGTMVEKDKLETQMGTMLINDED

Xenopus tropicalis            SKDLNTMKEFSTMNE-AADCTMVEKDKLNTQMGTMLINDED

Slime mold                    PRSMQNSGGEDNDEEYDTGTMVITDNK--NSYDTVVFNNDD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 487	Serine/threonine-protein kinase 4
Chain	327 – 487	Serine/threonine-protein kinase 4 18kDa subunit
Modified residue	340 – 340	Phosphothreonine
Modified residue	367 – 367	Phosphothreonine
Mutagenesis	349 – 349	D -> N. Resistant to proteolytic cleavage by caspase during apoptosis; when associated with N-326.

Literature citations
Patterns of somatic mutation in human cancer genomes.
Greenman C.; Stephens P.; Smith R.; Dalgliesh G.L.; Hunter C.; Bignell G.; Davies H.; Teague J.; Butler A.; Stevens C.; Edkins S.; O'Meara S.; Vastrik I.; Schmidt E.E.; Avis T.; Barthorpe S.; Bhamra G.; Buck G.; Choudhury B.; Clements J.; Cole J.; Dicks E.; Forbes S.; Gray K.; Halliday K.; Harrison R.; Hills K.; Hinton J.; Jenkinson A.; Jones D.; Menzies A.; Mironenko T.; Perry J.; Raine K.; Richardson D.; Shepherd R.; Small A.; Tofts C.; Varian J.; Webb T.; West S.; Widaa S.; Yates A.; Cahill D.P.; Louis D.N.; Goldstraw P.; Nicholson A.G.; Brasseur F.; Looijenga L.; Weber B.L.; Chiew Y.-E.; DeFazio A.; Greaves M.F.; Green A.R.; Campbell P.; Birney E.; Easton D.F.; Chenevix-Trench G.; Tan M.-H.; Khoo S.K.; Teh B.T.; Yuen S.T.; Leung S.Y.; Wooster R.; Futreal P.A.; Stratton M.R.;
Nature 446:153-158(2007)
Cited for: VARIANTS [LARGE SCALE ANALYSIS] ASN-162; GLN-310; MET-312; THR-355 AND LEU-416;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.